Gert A. Fricker - Publications

New Synthetic Strategies Toward DFO*: Enhanced Yield and Purity of a Key Chelator for 89Zr Chemistry.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 30, 2026

Macropa Scaffold Expansion for Actinium-225 Chelation: A Synthetic Strategy, Labeling Kinetics, and Theoretical Calculations.

Journal: Inorganic chemistry

Published: April 29, 2026

Effect of glyphosate and AMPA on expression and activity of ABC export proteins in killifish (Fundulus heteroclitus) kidney tubules.

Journal: Environmental toxicology and pharmacology

Published: February 19, 2026

A multi-level characterization of TfR, Mfsd2a and LRP1 in a stem cell derived in vitro model of the blood-brain barrier.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: February 12, 2026

Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 Nanobodies.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 01, 2026

Hydrogel and oleogel formulation of the decapeptide cetrorelix acetate for nasal administration.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 23, 2025

Editorial: New approaches to overcome the blood-brain barrier for the treatment of CNS disorders.

Journal: Frontiers in cellular neuroscience

Published: October 22, 2025

A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers.

Journal: mAbs

Published: September 22, 2025

Preclinical Evaluation of Stable Integrin αvβ3-Specific [198Au]Gold Nanoparticles for Tumor Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 22, 2025

Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 08, 2025

Design, Synthesis and Biological Evaluation of Chromeno[3,4-b]xanthones as Multifunctional Agents for Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: August 06, 2025

Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 30, 2025